Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Choosing Wisely for young women with breast cancer: BMC data

Dr Siddharth Turkar - Balco Medical Center, Raipur, India
Choosing Wisely for young women with breast cancer: BMC data ( Dr Siddharth Turkar - Balco Medical Center, Raipur, India )
22 Sep 2024

Choosing Wisely for young women with breast cancer: Radiotherapy

Dr Tabassum Wadasadawala - Tata Memorial Hospital, Mumbai, India
Choosing Wisely for young women with breast cancer: Radiotherapy ( Dr Tabassum Wadasadawala - Tata Memorial Hospital, Mumbai, India )
22 Sep 2024

Choosing Wisely for young women with breast cancer: Medical therapy

Dr Shriniwas Kulkarni - Sahyadri Superspeciality Hospital,Pune, India
Choosing Wisely for young women with breast cancer: Medical therapy ( Dr Shriniwas Kulkarni - Sahyadri Superspeciality Hospital,Pune, India )
22 Sep 2024

Choosing Wisely in endometrial & cervix cancers: Surgery

Dr Deepti Mishra - Tangham Cancer Center, Uttar Pradesh, India
Choosing Wisely in endometrial & cervix cancers: Surgery ( Dr Deepti Mishra - Tangham Cancer Center, Uttar Pradesh, India )
22 Sep 2024

Choosing Wisely in endometrial & cervix cancers: Medical therapy

Dr Jaya Ghosh - Tata Memorial Hospital, Mumbai, India
Choosing Wisely in endometrial & cervix cancers: Medical therapy ( Dr Jaya Ghosh - Tata Memorial Hospital, Mumbai, India )
22 Sep 2024

ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer

Prof Karim Fizazi, Dr Anders Bjartell, Dr Niven Mehra and Prof Eleni Efstathiou
ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer ( Prof Karim Fizazi, Dr Anders Bjartell, Dr Niven Mehra and Prof Eleni Efstathiou )
19 Sep 2024

Cancer mutation prediction using artificial intelligence

Dr Carlo Bifulco - Providence Cancer Institute, Southfield, USA
Cancer mutation prediction using artificial intelligence ( Dr Carlo Bifulco - Providence Cancer Institute, Southfield, USA )
16 Sep 2024

Mutational-based treatment approach may significantly improve outcomes in pretreated patients with metastatic solid tumours

Dr Andrea Botticelli - Sapienza Università di Roma, Rome, Italy
Mutational-based treatment approach may significantly improve outcomes in pretreated patients with metastatic solid tumours ( Dr Andrea Botticelli - Sapienza Università di Roma, Rome, Italy )
16 Sep 2024

Improved structure preservation with neo-adjuvant platinum-based chemo in patients with resectable NPNSCC

Prof Nabil F. Saba - Winship Cancer Institute of Emory University, Atlanta, USA
Improved structure preservation with neo-adjuvant platinum-based chemo in patients with resectable NPNSCC ( Prof Nabil F. Saba - Winship Cancer Institute of Emory University, Atlanta, USA )
15 Sep 2024

ESMO 2024: Optimising the personalisation of prostate cancer treatment

Prof Alison Birtle, Dr Alejo Rodríguez-Vida, Dr Pasquale Rescigno and Prof Gunhild von Amsberg
ESMO 2024: Optimising the personalisation of prostate cancer treatment ( Prof Alison Birtle, Dr Alejo Rodríguez-Vida, Dr Pasquale Rescigno and Prof Gunhild von Amsberg )
15 Sep 2024

ERBB2 amplifications across sex, race, and cancer types studied to guide HER2 therapies

Dr Marc Machaalani - Dana-Farber Cancer Institute, Boston, USA
ERBB2 amplifications across sex, race, and cancer types studied to guide HER2 therapies ( Dr Marc Machaalani - Dana-Farber Cancer Institute, Boston, USA )
14 Sep 2024

Repeat immune checkpoint inhibitor therapy not recommended for aRCC

Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
Repeat immune checkpoint inhibitor therapy not recommended for aRCC ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
14 Sep 2024